Literature DB >> 28314932

Impaired monocyte activation in schizophrenia: ultrastructural abnormalities and increased IL-1β production.

Natalya A Uranova1, P D Bonartsev2, L V Androsova3, V I Rakhmanova2, V G Kaleda4.   

Abstract

Monocyte activation is consistently reported in patients with schizophrenia (SZ). We aimed to study the ultrastructure of monocytes and monocyte production of IL-1β in drug-free patients with SZ and controls. Monocytes from young (18-30 y.o.) healthy and SZ men in relapse were studied. Electron microscopy and morphometry were applied to estimate areas of monocytes, volume density (Vv), areas, and number of organelles. The production IL-1β by monocytes was estimated by the ELISA method. Group differences were examined using ANCOVA. Pearson's correlation coefficients were used to examine the effects of possible confounding variables. Correlation analyses were applied to detect the relationships between the parameters of monocytes measured and between the parameters measured and the IL-1β production. Area of nucleolus, Vv and area of mitochondria and lysosomes, and the number of lysosomes were significantly increased in patients as compared to controls. Area of mitochondria was correlated significantly with Vv and area of lysosomes, and the number of lysosomes was significantly correlated with area of monocyte and Vv of vacuoles only in the control group. The production of IL-1β by monocytes was higher in patients than in controls (p = 0.01) and was correlated with Vv of lysosomes (r = 0.68, p = 0.04) and area of lysosomes (r = 0.78, p = 0.013). The data provide new evidence for over activation of monocytes in SZ and disturbed metabolic relationships between lysosomes, mitochondria, and vacuoles.

Entities:  

Keywords:  IL-1β production; Monocyte; Morphometry; Schizophrenia; Ultrastructure

Mesh:

Substances:

Year:  2017        PMID: 28314932     DOI: 10.1007/s00406-017-0782-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  33 in total

1.  Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia.

Authors:  J Kowalski; P Blada; K Kucia; A Madej; Z S Herman
Journal:  Schizophr Res       Date:  2001-07-01       Impact factor: 4.939

Review 2.  Are some cases of psychosis caused by microbial agents? A review of the evidence.

Authors:  R H Yolken; E F Torrey
Journal:  Mol Psychiatry       Date:  2008-02-12       Impact factor: 15.992

Review 3.  Mechanisms of communication between mitochondria and lysosomes.

Authors:  Nuno Raimundo; Lorena Fernández-Mosquera; King Faisal Yambire; Cátia V Diogo
Journal:  Int J Biochem Cell Biol       Date:  2016-09-06       Impact factor: 5.085

Review 4.  Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation.

Authors:  N Müller; M Riedel; M Ackenheil; M J Schwarz
Journal:  World J Biol Psychiatry       Date:  2000-10       Impact factor: 4.132

Review 5.  IL-1beta processing in host defense: beyond the inflammasomes.

Authors:  Mihai G Netea; Anna Simon; Frank van de Veerdonk; Bart-Jan Kullberg; Jos W M Van der Meer; Leo A B Joosten
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

6.  Immunological dysfunction in schizophrenia: a systematic approach.

Authors:  M Rothermundt; V Arolt; C Weitzsch; D Eckhoff; H Kirchner
Journal:  Neuropsychobiology       Date:  1998       Impact factor: 2.328

7.  [The effect of treatment on interleukin-1beta production in patients with first episode of juvenile psychosis].

Authors:  L V Androsova; V G Kaleda; A N Barkhatova; M Ia Tsutsul'kovskaia; G I Koliaskina
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2007

Review 8.  Mechanisms of interleukin-1beta release.

Authors:  Claudia Eder
Journal:  Immunobiology       Date:  2009-02-27       Impact factor: 3.144

9.  Mitochondrial Respiration Controls Lysosomal Function during Inflammatory T Cell Responses.

Authors:  Francesc Baixauli; Rebeca Acín-Pérez; Carolina Villarroya-Beltrí; Carla Mazzeo; Norman Nuñez-Andrade; Enrique Gabandé-Rodriguez; Maria Dolores Ledesma; Alberto Blázquez; Miguel Angel Martin; Juan Manuel Falcón-Pérez; Juan Miguel Redondo; Jose Antonio Enríquez; Maria Mittelbrunn
Journal:  Cell Metab       Date:  2015-08-20       Impact factor: 27.287

Review 10.  Linking Activation of Microglia and Peripheral Monocytic Cells to the Pathophysiology of Psychiatric Disorders.

Authors:  Yuta Takahashi; Zhiqian Yu; Mai Sakai; Hiroaki Tomita
Journal:  Front Cell Neurosci       Date:  2016-06-03       Impact factor: 5.505

View more
  9 in total

1.  Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP).

Authors:  Natalya S Weber; Kristin L Gressitt; David N Cowan; David W Niebuhr; Robert H Yolken; Emily G Severance
Journal:  Schizophr Res       Date:  2018-01-06       Impact factor: 4.939

2.  Abnormalities in the brain-immune system in psychotic disorders: from pathogenesis to prevention.

Authors:  Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08       Impact factor: 5.270

3.  The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study.

Authors:  Hussein Kadhem Al-Hakeim; Abbas F Almulla; Michael Maes
Journal:  Neurotox Res       Date:  2020-01-08       Impact factor: 3.911

4.  TRPM2 Channel Aggravates CNS Inflammation and Cognitive Impairment via Activation of Microglia in Chronic Cerebral Hypoperfusion.

Authors:  Jun Miyanohara; Masashi Kakae; Kazuki Nagayasu; Takayuki Nakagawa; Yasuo Mori; Ken Arai; Hisashi Shirakawa; Shuji Kaneko
Journal:  J Neurosci       Date:  2018-03-09       Impact factor: 6.167

5.  Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia.

Authors:  Yuan Gao; Yajuan Fan; Zai Yang; Qingyan Ma; Binbin Zhao; Xiaoyan He; Fengjie Gao; Li Qian; Wei Wang; Ce Chen; Yunchun Chen; Chengge Gao; Xiancang Ma; Feng Zhu
Journal:  Mol Psychiatry       Date:  2021-11-02       Impact factor: 15.992

6.  Association between CpG island DNA methylation in the promoter region of RELN and positive and negative types of schizophrenia.

Authors:  Junjie Zhou; Dajin Zhou; Tielun Yan; Weifeng Chen; Hejie Xie; Yan Xiong
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

Review 7.  Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

Authors:  Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg
Journal:  Behav Brain Res       Date:  2021-01-14       Impact factor: 3.332

8.  1Q12 Loci Movement in the Interphase Nucleus Under the Action of ROS Is an Important Component of the Mechanism That Determines Copy Number Variation of Satellite III (1q12) in Health and Schizophrenia.

Authors:  Marina Sergeevna Konkova; Elizaveta Sergeevna Ershova; Ekaterina Alekseevna Savinova; Elena Mikhailovna Malinovskaya; Galina Vasilievna Shmarina; Andrey Vladimirovich Martynov; Roman Vladimirovich Veiko; Nataly Vyacheslavovna Zakharova; Pavel Umriukhin; Georgy Petrovich Kostyuk; Vera Leonidovna Izhevskaya; Sergey Ivanovich Kutsev; Natalia Nikolaevna Veiko; Svetlana Victorovna Kostyuk
Journal:  Front Cell Dev Biol       Date:  2020-06-05

9.  Monocytic Subsets Impact Cerebral Cortex and Cognition: Differences Between Healthy Subjects and Patients With First-Episode Schizophrenia.

Authors:  Song Chen; Fengmei Fan; Fang-Ling Xuan; Ling Yan; Meihong Xiu; Hongzhen Fan; Yimin Cui; Ping Zhang; Ting Yu; Fude Yang; Baopeng Tian; L Elliot Hong; Yunlong Tan; Li Tian
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.